Observational study on the response of tenofovir monotherapy versus tenofovir plus telbivudine dual therapy in patients with hepatitis B virus related acute on chronic liver failure

INTRODUCTION: HBV is major health problem globally due to complications, including ACLF, cirrhosis and hepa¬tocellular carcinoma. ACLF due to exacerbation of CHB is associate with 30%-70% mortality. Reduction of HBV-DNA is therefore a target of therapy in ACLF-B. METHODS: Patients with spontaneous r...

Descripción completa

Detalles Bibliográficos
Autores principales: Manik, Abul H, Malakar, Debraj, Noor-E-Alam, Sheikh M, Mahtab, Mamun A, Das, Dulal C, Mamun, Ayub A, Khan, Sakirul, Akbar, Mohammad Fazle, Rahman, Zakiur, Rahman, Salimur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284233/
https://www.ncbi.nlm.nih.gov/pubmed/34322441
http://dx.doi.org/10.4103/jfmpc.jfmpc_2300_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284233/
https://www.ncbi.nlm.nih.gov/pubmed/34322441
http://dx.doi.org/10.4103/jfmpc.jfmpc_2300_20

Ejemplares similares